ESC 365 - Rapid Fire session 8 - Atrial fibrillation and stroke prevention
American Heart Journal American Heart Journal
Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study - European Journal of Internal Medicine
Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry - American Journal of Cardiology
Design of GLORIA-AF. m, months; NOAC non-vitamin K antagonist oral... | Download Scientific Diagram
Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry - American Journal of Cardiology
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry
Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II - The American Journal of Medicine
The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA -AF Registry Phase 2 - ScienceDirect
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry | SpringerLink
Influence of BMI and geographical region on prescription of oral anticoagulants in newly diagnosed atrial fibrillation: The GLORIA-AF Registry Program - European Journal of Internal Medicine
GLORIA AF Registry delivery from ESC Ph D
Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF | PLOS ONE
Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA‐AF Phase III Registry | Journal of the American Heart Association
GLORIA™-AF REGISTRY PROGRAMME
GLORIA AF, Phase 2 Flow Chart. | Download Scientific Diagram
Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry
GLORIA AF Registry delivery from ESC Ph D
Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA‐AF registry - Ma - 2020 - Journal of Arrhythmia - Wiley Online Library
